Investing

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

In light of the XRG AGM being held today, the board would like to provide the market with the latest sales performance information on Operator XR since the last market update on the 31st October 2024 contained within the Quarterly Activities Report and Appendix 4C.

Highlights

Total Contract Value of $7.13m in FY25 YTD vs $4.1M EOFY24
Annual Recurring Revenue $3.54m increase of 59% from EOFY24
United States Department of Defence Project ($5.6m) on track

Operator XR Annual Recurring Revenue (ARR)

Total ARR = $3,538,580
ARR increase since 1st October = $496,885 (+16%)

Operator XR Total Contract Value (TCV)

Total TCV YTD = $7,130,955
Total TCV increase since 1st October = $882,351 (+14%)

XRG CEO Wayne Jones said, “The remarkable penetration of Operator XR across both the Law Enforcement and Military markets, particularly in the United States of America, has continued throughout the early stages of the financial year. The exposure gained through major customers, including the US Department of Defence, is beginning to open new opportunities to other federal agencies and brings further validation to the Operator XR software.”

Click here for the full ASX Release

This post appeared first on investingnews.com

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version